Replies to post #43488 on Delcath Systems Inc (DCTH)

[benandemmiboo]

fair enough comment, but most investors would consider an offer valuing Delcath at, say, $12-20 million MC, to be a cheap acquisition.

If Delcath has been unable to secure decent financing, then Delcath would have to recommend that the best offer, however low, be accepted...

Of course, this scenario might not happen, but it's the one I'll likely be gambling on. Right now, at 1 million shares, there is no reason this stock has been this unexciting for the past week or 2 without some entity on either side helping to keep fireworks from happening.

[tickerpicker]

You know as well as I do that there is no way Management initiated another FDA trial if they did not already have something lined up. No way they just thought that things have been going so well that they could afford to launch and maintain a second FDA trial with funding operations in this same manner. I think they wanted to make sure it ICC FDA trial would be official so would be considered a real asset that would need to be calculated into BO/Merger valuation. They have been going down a checklist of company issues and fixing as best as possible under the circumstances for a possible future acquirer to make company more attractive and increase value. I believe are now shopping it around. Hence all the PR. Management will no doubt get their golden parachute, or possibly even keep their positions in the transaction. But with a high level of oversite.
Like always nothing is guaranteed but defiantly a scenario that needs some serious consideration IMO.